Phreesia, Inc. (NYSE:PHR) COO Sells $48,159.30 in Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 1,785 shares of the company’s stock in a transaction dated Wednesday, January 15th. The shares were sold at an average price of $26.98, for a total transaction of $48,159.30. Following the transaction, the chief operating officer now directly owns 768,208 shares of the company’s stock, valued at approximately $20,726,251.84. This trade represents a 0.23 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Evan Roberts also recently made the following trade(s):

• On Wednesday, January 8th, Evan Roberts sold 2,681 shares of Phreesia stock. The shares were sold at an average price of $27.95, for a total value of $74,933.95.
• On Monday, January 6th, Evan Roberts sold 2,873 shares of Phreesia stock. The stock was sold at an average price of $26.61, for a total value of $76,450.53.

Phreesia Trading Up 1.6 %

Phreesia stock opened at $27.24 on Monday. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $29.16. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. The business’s fifty day simple moving average is $23.54 and its two-hundred day simple moving average is $22.83. The company has a market capitalization of $1.58 billion, a price-to-earnings ratio of -18.53 and a beta of 0.94.

Phreesia (NYSE:PHR) last announced its quarterly earnings data on Monday, December 9th. The company reported ($0.25) EPS for the quarter, beating the consensus estimate of ($0.29) by $0.04. The company had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. Phreesia’s revenue for the quarter was up 16.6% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.58) EPS. As a group, equities analysts predict that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on PHR. Robert W. Baird dropped their price target on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research note on Wednesday, December 11th. Royal Bank of Canada upgraded shares of Phreesia from a “sector perform” rating to an “outperform” rating and boosted their price target for the company from $24.00 to $32.00 in a research report on Wednesday, January 8th. Needham & Company LLC restated a “buy” rating and issued a $29.00 price objective on shares of Phreesia in a report on Friday, January 10th. KeyCorp lifted their price objective on Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a research report on Wednesday, January 8th. Finally, Truist Financial increased their target price on Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. Twelve investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the company has an average rating of “Buy” and an average target price of $31.00.

Institutional Investors Weigh In On Phreesia

Several institutional investors and hedge funds have recently made changes to their positions in the company. Wesbanco Bank Inc. boosted its stake in Phreesia by 76.9% during the 4th quarter. Wesbanco Bank Inc. now owns 46,000 shares of the company’s stock valued at $1,157,000 after purchasing an additional 20,000 shares during the last quarter. Franklin Resources Inc. raised its position in Phreesia by 3.0% in the 3rd quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock worth $31,495,000 after buying an additional 42,973 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Phreesia by 4.7% during the 3rd quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company’s stock valued at $28,397,000 after acquiring an additional 55,934 shares during the last quarter. M&T Bank Corp grew its stake in shares of Phreesia by 4.6% in the third quarter. M&T Bank Corp now owns 35,127 shares of the company’s stock worth $801,000 after acquiring an additional 1,535 shares during the period. Finally, Barclays PLC raised its holdings in shares of Phreesia by 83.6% during the third quarter. Barclays PLC now owns 94,929 shares of the company’s stock valued at $2,163,000 after purchasing an additional 43,225 shares during the last quarter. Institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.